Sarcoidosis Biomarkers
Cross-source consensus on Sarcoidosis Biomarkers from 1 sources and 4 claims.
1 sources · 4 claims
Risks & contraindications
Evidence quality
Highlighted claims
- No validated biomarkers currently distinguish progressive sarcoidosis from non-progressive sarcoidosis. — Molecular characterisation of progressive pulmonary sarcoidosis: protocol for a longitudinal multi-centre study to develop peripheral blood circulating biomarkers for predicting pulmonary sarcoidosis progression
- Prior blood-based gene expression signatures involving T-cell receptor signalling and CXCL9 have not been independently validated. — Molecular characterisation of progressive pulmonary sarcoidosis: protocol for a longitudinal multi-centre study to develop peripheral blood circulating biomarkers for predicting pulmonary sarcoidosis progression
- The lack of reliable biomarkers has reduced clinical trial quality by enrolling stable or remitting participants. — Molecular characterisation of progressive pulmonary sarcoidosis: protocol for a longitudinal multi-centre study to develop peripheral blood circulating biomarkers for predicting pulmonary sarcoidosis progression
- Preliminary data suggest blood-derived and PBMC-derived molecular signatures may distinguish progressive and non-progressive sarcoidosis. — Molecular characterisation of progressive pulmonary sarcoidosis: protocol for a longitudinal multi-centre study to develop peripheral blood circulating biomarkers for predicting pulmonary sarcoidosis progression